Skip to main content

British Columbia Overdose deaths are shrinking in B.C. but a powerful drug becomes more common

The powerful opioid carfentanil, a drug experts say is 100 times stronger than fentanyl, was found in one-quarter of the fentanyl-detected deaths.

The Associated Press

The latest update for illicit drug deaths in British Columbia shows a downward trend for the first five months of this year.

The BC Coroners Service says 84 people died in May, compared with 116 the year before.

Over all, 462 illicit drug-toxicity deaths have been recorded so far this year, down 30 per cent from the same period in 2018.

Story continues below advertisement

The coroner says two-thirds of those who died are people between 30 and 59, and males account for almost four out of five of the deaths.

The powerful opioid carfentanyl, a drug experts say is 100 times stronger than fentanyl, was found in one-quarter of the fentanyl-detected deaths.

The coroner says no deaths have been reported at supervised consumption or overdose prevention sites in the province.

Our Morning Update and Evening Update newsletters are written by Globe editors, giving you a concise summary of the day’s most important headlines. Sign up today.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter